Predicting Parkinson's disease - why, when, and how?

Parkinsonism and Related Disorders

Volumn 15, Issue SUPPL. 3, 2009, Pages

  Postuma, R B ^a,b   Montplaisir, J ^b,c  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Neuroprotection; Parkinson's disease; Prediction; REM sleep behavior disorder

Indexed keywords

ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; BEHAVIOR DISORDER; BRAIN REGION; BRAIN STEM; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; ECHOGRAPHY; HUMAN; INSOMNIA; MOTOR DYSFUNCTION; NEUROPROTECTION; PARASOMNIA; PARKINSON DISEASE; PERSONALITY DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMELLING DISORDER; SOMNOLENCE; SUBSTANTIA NIGRA; VISUAL IMPAIRMENT;

AUTONOMIC NERVOUS SYSTEM DISEASES; BRAIN STEM; DEPRESSION; DISEASE PROGRESSION; HUMANS; OLFACTION DISORDERS; PARKINSON DISEASE; PERSONALITY; PREDICTIVE VALUE OF TESTS; SLEEP DISORDERS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VISION DISORDERS;

EID: 71849089217     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(09)70793-X     Document Type: Article

References (65)

1. Tibben A. Predictive testing for Huntington's disease. Brain Res Bull 72 (2007) 165-171
2. de Lau L.M., and Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol 5 (2006) 525-535
3. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., et al. Parkinson disease in twins: an etiologic study. JAMA 281 (1999) 341-346
4. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 (2003) 197-211
5. Braak H., Sastre M., Bohl J.R., de Vos R.A., and Del T.K. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113 (2007) 421-429
6. Zaccai J., Brayne C., McKeith I., Matthews F., and Ince P.G. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. Neurology 70 (2008) 1042-1048
7. Halliday G., Hely M., Reid W., and Morris J. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 115 (2008) 409-415
8. Dickson D.W., Fujishiro H., Delledonne A., Menke J., Ahmed Z., Klos K.J., et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol 115 (2008) 437-444
9. Kalaitzakis M.E., Graeber M.B., Gentleman S.M., and Pearce R.K. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol 34 (2008) 284-295
10. Parkkinen L., Pirttila T., and Alafuzoff I. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115 (2008) 399-407
11. Orimo S., Takahashi A., Uchihara T., Mori F., Kakita A., Wakabayashi K., et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 17 (2007) 24-30
12. Chaudhuri K.R., Healy D.G., and Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5 (2006) 235-245
13. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57 (2001) 456-462
14. Spiegel J., Hellwig D., Farmakis G., Jost W.H., Samnick S., Fassbender K., et al. Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord 22 (2007) 1004-1008
15. Braak H., and Del T.K. Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology 70 (2008) 1916-1925
16. Hawkes C. Olfaction in neurodegenerative disorder. Mov Disord 18 (2003) 364-372
17. Olichney J.M., Murphy C., Hofstetter C.R., Foster K., Hansen L.A., Thal L.J., et al. Anosmia is very common in the Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry 76 (2005) 1342-1347
18. Doty R.L., Shaman P., and Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32 (1984) 489-502
19. Hummel T., Sekinger B., Wolf S.R., Pauli E., and Kobal G. 'Sniffin' Sticks': Olfactory performance assessed by the combined testing of odour identification, odor discrimination and olfactory threshold. Chemical Senses 22 (1997) 39-52
20. Berendse H.W., Booij J., Francot C.M., Bergmans P.L., Hijman R., Stoof J.C., et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 50 (2001) 34-41
21. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., Wolters E.C., and Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56 (2004) 173-181
22. Ross G.W., Petrovitch H., Abbott R.D., Tanner C.M., Popper J., Masaki K., et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 63 (2008) 167-173
23. Marras C., Goldman S., Smith A., Barney P., Aston D., Comyns K., Korell M., et al. Smell identification ability in twin pairs discordant for Parkinson's disease. Mov Disord 20 (2005) 687-693
24. Frisina P.G., Haroutunian V., and Libow L.S. The neuropathological basis for depression in Parkinson's disease. Parkinsonism Relat Disord 15 (2009 Feb) 572-575
25. Lieberman A. Depression in Parkinson's disease - a review. Acta Neurol Scand 113 (2006) 1-8
26. Walter U., Hoeppner J., Prudente-Morrissey L., Horowski S., Herpertz S.C., and Benecke R. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130 (2007) 1799-1807
27. Leentjens A.F., Van den A.M., Metsemakers J.F., Lousberg R., and Verhey F.R. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 18 (2003) 414-418
28. Ishihara L., and Brayne C. A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand 113 (2006) 211-220
29. Ishihara L., and Brayne C. What is the evidence for a premorbid parkinsonian personality: a systematic review. Mov Disord 21 (2006) 1066-1072
30. Abbott R.D., Ross G.W., White L.R., Tanner C.M., Masaki K.H., Nelson J.S., et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65 (2005) 1442-1446
31. Price M.J., Feldman R.G., Adelberg D., and Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology 42 (1992) 887-890
32. Muller T., Woitalla D., Peters S., Kohla K., and Przuntek H. Progress of visual dysfunction in Parkinson's disease. Acta Neurol Scand 105 (2002) 256-260
33. Gaenslen A., Unmuth B., Godau J., Liepelt I., Di S.A., Schweitzer K.J., et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 7 (2008) 417-424
34. Berg D., Becker G., Zeiler B., Tucha O., Hofmann E., Preier M., et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53 (1999) 1026-1031
35. Spiegel J., Hellwig D., Mollers M.O., Behnke S., Jost W., Fassbender K., et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 129 (2006) 1188-1193
36. Berg D., Merz B., Reiners K., Naumann M., and Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 20 (2005) 383-385
37. Montgomery Jr. E.B., Lyons K., and Koller W.C. Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery. Mov Disord 15 (2000) 474-478
38. Bennett D.A., Beckett L.A., Murray A.M., Shannon K.M., Goetz C.G., Pilgrim D.M., et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334 (1996) 71-76
39. Ravina B., Eidelberg D., Ahlskog J.E., Albin R.L., Brooks D.J., Carbon M., et al. The role of radiotracer imaging in Parkinson disease. Neurology 64 (2005) 208-215
40. Morrish P.K., Rakshi J.S., Bailey D.L., Sawle G.V., and Brooks D.J. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 64 (1998) 314-319
41. Hilker R., Schweitzer K., Coburger S., Ghaemi M., Weisenbach S., Jacobs A.H., et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol 62 (2005) 378-382
42. Vingerhoets F.J., Snow B.J., Lee C.S., Schulzer M., Mak E., and Calne D.B. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol 36 (1994) 759-764
43. Gagnon J.F., Postuma R.B., Mazza S., Doyon J., and Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 5 (2006) 424-432
44. Boeve B.F., Silber M.H., Saper C.B., Ferman T.J., Dickson D.W., Parisi J.E., et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130 (2007) 2770-2788
45. Iranzo A., Molinuevo J.L., Santamaria J., Serradell M., Marti M.J., Valldeoriola F., et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5 (2006) 572-577
46. Schenck C.H., Bundlie S.R., and Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46 (1996) 388-393
47. Postuma R.B., Gagnon J.F., Vendette M., Fantini M.L., Massicotte-Marquez J., and Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72 (2009) 1296-1300
48. Stiasny-Kolster K., Mayer G., Schafer S., Moller J.C., Heinzel-Gutenbrunner M., and Oertel W.H. The REM sleep behavior disorder screening questionnaire - A new diagnostic instrument. Mov Disord 22 (2007) 2386-2393
49. de Rijk M.C., Launer L.J., Berger K., Breteler M.M., Dartigues J.F., Baldereschi M., et al., Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54 (2000) S21-S23
50. Postuma R.B., Gagnon J.F., Vendette M., and Montplaisir J. Markers of neurodegeneration in idiopathic REM sleep behavior disorder and Parkinson disease. Brain (2009 Oct) [Epub ahead of print].
51. Postuma R.B., Lang A.E., Massicotte-Marquez J., and Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 66 (2006) 845-851
52. Fantini M.L., Postuma R.B., Montplaisir J., and Strambini L.F. Olfactory impairment in idiopathic and symptomatic REM sleep behavior disorder. Brain Res Bull 16 (2006) 386-390
53. Postuma R.B., Gagnon J.F., Vendette M., and Montplaisir J. Idiopathic REM sleep behavior disorder in the transition to degenerative disease. Mov Disord (2009 Sep 18) [Epub ahead of print].
54. Miyamoto T., Miyamoto M., Inoue Y., Usui Y., Suzuki K., and Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology 67 (2006) 2236-2238
55. Eisensehr I., Linke R., Noachtar S., Schwarz J., Gildehaus F.J., and Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 123 (2000) 1155-1160
56. Stiasny-Kolster K., Doerr Y., Moller J.C., Hoffken H., Behr T.M., Oertel W.H., et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128 (2005) 126-137
57. Unger M.M., Moller J.C., Stiasny-Kolster K., Mankel K., Berg D., Walter U., et al. Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT. Mov Disord 23 (2008) 596-599
58. Mazza S., Soucy J.P., Gravel P., Michaud M., Postuma R., Massicotte-Marquez J., et al. Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology 67 (2006) 1618-1622
59. Moeller J.R., and Eidelberg D. Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing. Brain 120 Pt 12 (1997) 2197-2206
60. Massicotte-Marquez J., Decary A., Gagnon J.F., Vendette M., Mathieu A., Postuma R.B., et al. Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology 70 (2008) 1250-1257
61. Gagnon J.F., Vendette M., Postuma R.B., Desjardins C., Massicotte-Marquez J., Panisset M., et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol 66 (2009) 39-47
62. Postuma R.B., Gagnon J.F., Vendette M., Charland K., and Montplaisir J. Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Movement Disorders 23 (2008) 1665-1672
63. Postuma R.B., Gagnon J.F., Vendette M., Massicotte-Marquez J., Charland K., and Montplaisir J. REM sleep behavior disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry 79 (2008) 1117-1121
64. Vendette M., Gagnon J.F., Decary A., Massicotte-Marquez J., Postuma R.B., Doyon J., et al. REM Sleep Behavior Disorder Predicts Cognitive Impairment in Parkinson's Disease without Dementia. Neurology 69 (2007) 1843-1849
65. Kumru H., Santamaria J., Tolosa E., and Iranzo A. Relation between subtype of Parkinson's disease and REM sleep behavior disorder. Sleep Med 8 (2007) 779-783